Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 2, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Design Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Design Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Design Therapeutics, Inc.
| -590.88K |
$19.07 | -$11,266,197.49 | -12.52% | 4.13M |
Mar 18 - Mar 22
| |||||||
Tempest Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Tempest Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Millendo Therapeutics, Inc.
| 579.71K |
—
|
—
|
∞
| 579.71K |
Jun 25
| |||||||
Millendo Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Nextcure, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Design Therapeutics, Inc.
| 4.73M |
$20.00 | $200,000.00 | +100.21% | 9.45M |
Mar 30
| |||||||
Design Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 25
| |||||||
Design Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Nextcure, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Nextcure, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Nextcure, Inc.
| 1.1M |
$15.00 |
—
|
∞
| 1.1M |
May 13
| |||||||
Nextcure, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Armo Biosciences, Inc.
| -404.90K |
$50.00 | -$20,245,000.00 | -100.00% |
0
|
Jun 22
| |||||||
Armo Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 26
| |||||||
Armo Biosciences, Inc.
| 404.9K |
—
|
—
|
∞
| 404.9K |
Jan 30
| |||||||
Armo Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |